Aytu Biopharma Inc (NQ: AYTU )
2.500
+0.050
(+2.04%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Aytu Biopharma Inc
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_11899.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/05/17/aapharma_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/07/01/image11.jpg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
From Aytu BioPharma, Inc.
Via AccessWire
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6632.jpeg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_7385.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
From Aytu BioPharma, Inc.
Via AccessWire
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_7162.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_6821.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_6773.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/20/yesterdays_movers.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
From Aytu BioPharma, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
From Aytu BioPharma, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
From Aytu BioPharma, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3316.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_236.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/test-gcd00d1810_1280_0.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
Aytu BioPharma Completes $15 Million Debt Refinancing
January 31, 2022
From Aytu BioPharma, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.